Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.

Astor BC, Hallan SI, Miller ER 3rd, Yeung E, Coresh J.

Am J Epidemiol. 2008 May 15;167(10):1226-34. doi: 10.1093/aje/kwn033. Epub 2008 Apr 2.

PMID:
18385206
2.

Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rate.

Cirillo M, Lanti MP, Menotti A, Laurenzi M, Mancini M, Zanchetti A, De Santo NG.

Arch Intern Med. 2008 Mar 24;168(6):617-24. doi: 10.1001/archinte.168.6.617.

PMID:
18362254
3.

Albuminuria, but not estimated glomerular filtration rate, is associated with maladaptive arterial remodeling: the Hoorn Study.

Hermans MM, Henry RM, Dekker JM, Nijpels G, Heine RJ, Stehouwer CD.

J Hypertens. 2008 Apr;26(4):791-7. doi: 10.1097/HJH.0b013e3282f50066.

PMID:
18327090
4.

Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study.

Hallan S, Astor B, Romundstad S, Aasarød K, Kvenild K, Coresh J.

Arch Intern Med. 2007 Dec 10;167(22):2490-6.

PMID:
18071172
5.

Prevalence of chronic kidney disease in the United States.

Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS.

JAMA. 2007 Nov 7;298(17):2038-47.

PMID:
17986697
6.

Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes.

Foster MC, Hwang SJ, Larson MG, Parikh NI, Meigs JB, Vasan RS, Wang TJ, Levy D, Fox CS.

Arch Intern Med. 2007 Jul 9;167(13):1386-92.

PMID:
17620532
7.

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS.

Ann Intern Med. 2006 Aug 15;145(4):237-46.

PMID:
16908914
8.

Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus.

Sukhija R, Aronow WS, Kakar P, Garza L, Sachdeva R, Sinha A, Mehta JL.

Am J Cardiol. 2006 Aug 1;98(3):279-81. Epub 2006 Jun 6.

PMID:
16860009
9.

Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial.

Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M; Cholesterol and Recurrent Events (CARE) Trial Investigators.

BMJ. 2006 Jun 17;332(7555):1426. Epub 2006 May 19.

10.
11.

Glomerular filtration rate estimated by cystatin C among different clinical presentations.

Rule AD, Bergstralh EJ, Slezak JM, Bergert J, Larson TS.

Kidney Int. 2006 Jan;69(2):399-405.

12.

Cystatin-C and inflammatory markers in the ambulatory elderly.

Shlipak MG, Katz R, Cushman M, Sarnak MJ, Stehman-Breen C, Psaty BM, Siscovick D, Tracy RP, Newman A, Fried L.

Am J Med. 2005 Dec;118(12):1416.

PMID:
16378798
13.

The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health Study.

Cao JJ, Barzilay JI, Peterson D, Manolio TA, Psaty BM, Kuller L, Wexler J, Bleyer AJ, Cushman M.

Atherosclerosis. 2006 Aug;187(2):372-7. Epub 2005 Oct 20.

PMID:
16242696
14.

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study.

Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D'Agostino RB, Vasan RS.

Circulation. 2005 Aug 16;112(7):969-75. Epub 2005 Aug 8.

15.

Cystatin C and the risk of death and cardiovascular events among elderly persons.

Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C.

N Engl J Med. 2005 May 19;352(20):2049-60.

16.

Evaluation of measures of urinary albumin excretion in epidemiologic studies.

Dyer AR, Greenland P, Elliott P, Daviglus ML, Claeys G, Kesteloot H, Ueshima H, Stamler J; INTERMAP Research Group.

Am J Epidemiol. 2004 Dec 1;160(11):1122-31.

PMID:
15561992
17.

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY.

N Engl J Med. 2004 Sep 23;351(13):1296-305. Erratum in: N Engl J Med. 2008;18(4):4.

18.

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

J Am Soc Nephrol. 2004 May;15(5):1307-15.

19.

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Hypertension. 2003 Nov;42(5):1050-65. Review. No abstract available.

20.

Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals.

Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, Kuller LH, Newman AB.

J Am Coll Cardiol. 2003 Apr 16;41(8):1364-72.

Supplemental Content

Support Center